Delivery Order SPE2DR25D3111-SPE2DR26FF3XB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) with a ceiling value of $2,155.26 and a completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger federal contract vehicle. The performance location is the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $2,975.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 6, 2026, for dextroamphetamine-amphetamine 15 mg capsules (100-count bottles) with a ceiling value of $1,125.13. This firm fixed-price delivery order, which has an ultimate completion date of January 7, 2026, represents a task order issued under a larger Indefinite Delivery Contract vehicle. The contract was not set...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $1,131.09. This is a firm fixed price delivery order with no set-aside designation, issued competitively. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a ceiling value of $1,460.67. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,039.44 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitively awarded, firm fixed-price order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $1,185.70. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,986.62 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitive award, which carries no set-aside designation, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a firm fixed-price delivery order executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a ceiling value of $1,973.18 and a firm fixed price structure. This competitively awarded, non-set-aside delivery order is scheduled for ultimate completion by December 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a contract ceiling value of $1,594.31. This firm fixed-price delivery order, which is set to be completed by December 19, 2025, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis and represents a child contract under...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3XBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) at a ceiling value of $1,252.01. The contract is a firm fixed-price delivery order with an ultimate completion date of January 16, 2026, and represents performance from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made on a non-set-aside basis through open competition. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical through December 31, 2031, serving as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of therapeutic medications, including controlled substances such as the amphetamine product in this delivery order, alongside specialty medications, vaccines, and medical devices across multiple therapeutic domains. The firm fixed-price structure and rapid completion timeline reflect the operational nature of delivery orders executed under the larger DLA pharmaceutical supply vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/14/26 |